Refine by MP, party, committee, province, or result type.
Health committee Good morning. All marketed health products have risks associated with their use. Prescription drugs, over-the-counter products, biological, vaccines, medical devices and natural health products all have risks. Some of these risks are known at the time of market authorization, bu
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee So your question is about whether we can identify emerging safety signals in pharmaceuticals. I think tremendous progress has been accomplished in the past few years in that area, especially very recently with the creation of the Canada Vigilance online database. It is a new dat
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee The technology to give some estimation of the numbers of adverse events that have been reported to Health Canada for a specific drug and/or a specific adverse event is in place now. There's a delay because the adverse events reports have to be processed, looked at by a specialist
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee I think it's an area in which we're making step-by-step progress. A recent improvement is the ability to submit spontaneous adverse drug reaction information electronically. There is also now the capacity to search the spontaneous adverse drug reaction database online. Although
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee We use the Canadian Adverse Reaction Newsletter as one way of identifying clusters of cases. It's distributed to all physicians in Canada with the Canadian Medical Association Journal. So we have different ways to go back to the physician to--
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee On the first point, about the definitions, there is currently a definition in the food and drug regulations of an adverse drug reaction. There is also a definition of a serious adverse drug reaction. So these definitions do currently exist in the food and drug regulations. On th
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee If I understand your question well, you're wondering how we're going to leverage or how we're going to collaborate more with international agencies to gather more information?
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee Based on international references, somewhere between 1% and 10% are reported in Canada. We don't know exactly, because there is no way to exactly estimate the real occurrences. One concept that is important to understand is that a spontaneous ADR system is not necessarily there
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee We do have memoranda of understanding with countries such as the United States and the European medicine evaluation agencies, as well as with Australia, Singapore, and Swissmedic. So we do have these types of collaborations; whenever there are emerging safety issues, we can conta
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee Regarding mandatory reporting by physicians, the current plan is basically to consider--
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee Hospitals, yes. That will help, because some of the serious adverse drug reactions will bring people to consult in an emergency, so that will enable us to identify, maybe earlier, these signals that need to be further investigated.
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee Yes, there has been consultation with numerous stakeholders or representatives of the public and patient interest groups, physicians, and industry. The general consensus was that there was not necessarily a net gain in having all spontaneous adverse drug reactions reported, but m
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee If we take the post-market adverse event report for pharmaceuticals, from any source, whether they come from the manufacturers or consumers or health care professionals, they will all end up in the same area, which is the Canada Vigilance database. This is where the Canadian repo
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee Yes, there are numerous tools used to report back. This is one of the tools we use to identify emerging safety signals. So in that sense, if we take action, that's some kind of retroaction to the Canadian public and to the reporters. It's indirect, but that's one source of retroa
May 1st, 2008Committee meeting
Dr. Marc Berthiaume
Health committee The Canadian Adverse Reaction Newsletter is published every three months, so it's quarterly.
May 1st, 2008Committee meeting
Dr. Marc Berthiaume